Arcus Biosciences Inc (RCUS)
16.99
+0.55
(+3.35%)
USD |
NYSE |
Dec 04, 14:13
Arcus Biosciences Price to Book Value: 2.752 for Dec. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 03, 2024 | 2.663 |
| December 02, 2024 | 2.582 |
| November 29, 2024 | 2.501 |
| November 27, 2024 | 2.559 |
| November 26, 2024 | 2.558 |
| November 25, 2024 | 2.358 |
| November 22, 2024 | 2.381 |
| November 21, 2024 | 2.313 |
| November 20, 2024 | 2.368 |
| November 19, 2024 | 2.350 |
| November 18, 2024 | 2.337 |
| November 15, 2024 | 2.543 |
| November 14, 2024 | 2.554 |
| November 13, 2024 | 2.661 |
| November 12, 2024 | 2.716 |
| November 11, 2024 | 2.875 |
| November 08, 2024 | 2.891 |
| November 07, 2024 | 2.666 |
| November 06, 2024 | 2.548 |
| November 05, 2024 | 2.476 |
| November 04, 2024 | 2.520 |
| November 01, 2024 | 2.510 |
| October 31, 2024 | 2.478 |
| October 30, 2024 | 2.592 |
| October 29, 2024 | 2.658 |
| Date | Value |
|---|---|
| October 28, 2024 | 2.698 |
| October 25, 2024 | 2.643 |
| October 24, 2024 | 2.888 |
| October 23, 2024 | 2.806 |
| October 22, 2024 | 2.721 |
| October 21, 2024 | 2.748 |
| October 18, 2024 | 2.986 |
| October 17, 2024 | 2.954 |
| October 16, 2024 | 2.892 |
| October 15, 2024 | 2.879 |
| October 14, 2024 | 2.930 |
| October 11, 2024 | 2.975 |
| October 10, 2024 | 2.769 |
| October 09, 2024 | 2.873 |
| October 08, 2024 | 2.829 |
| October 07, 2024 | 2.802 |
| October 04, 2024 | 2.696 |
| October 03, 2024 | 2.479 |
| October 02, 2024 | 2.492 |
| October 01, 2024 | 2.497 |
| September 30, 2024 | 2.476 |
| September 27, 2024 | 2.219 |
| September 26, 2024 | 2.216 |
| September 25, 2024 | 2.199 |
| September 24, 2024 | 2.246 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.551
Minimum
May 11 2022
14.00
Maximum
Jun 02 2020
3.275
Average
2.728
Median
Nov 11 2020
Price to Book Value Benchmarks
| Merck & Co Inc | 5.792 |
| Regeneron Pharmaceuticals Inc | 2.813 |
| NovaBay Pharmaceuticals Inc | 2.750 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.361 |
Price to Book Value Related Metrics
| PS Ratio | 5.554 |
| Price | 16.99 |
| Earnings Yield | -18.54% |
| Market Cap | 1.555B |